Out of stock
Expiry Date: April 2024
REPL Cancetron: The medicine acts favourably and modifies all cases in which either a history of carcinoma can be elicited.
There are no reviews yet.
Your email address will not be published. Required fields are marked *
Your review *
Save my name, email, and website in this browser for the next time I comment.